Palatin

Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena
Thu, 06/13/24 - 11:03 am
Palatin
clinical trials
breatelanotide
obesity
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Palatin's Female Sexual Function Drug Succeeds, Offers Large Upside
Seeking Alpha
Wed, 11/9/16 - 09:51 am
Palatin
female sexual dysfunction
bremelanotide
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Thu, 09/8/16 - 09:50 am
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
NJ biotech firm develops 'female Viagra' for women with low sexual desire
The Star Ledger, NJ
Sun, 04/20/14 - 10:02 am
bremelanotide
Palatin
female sexual dysfunction
Targeting An Untapped Female Sexual Dysfunction Drug Market
Seeking Alpha
Tue, 09/3/13 - 11:23 am
female sexual dysfunction
Osphena
Shionogi
flibanserin
Sprout Pharmaceuticals
bremelanotide
Palatin
Femprox
Apricus Biosciences
Biotech Stock Mailbag: Amarin, MannKind, Palatin
The Street
Fri, 05/24/13 - 10:45 am
Amarin
MannKind
Palatin
Palatin Investors Prepared For The Long Haul With Another FSD Drug
Seeking Alpha
Wed, 11/14/12 - 12:25 pm
Palatin
FSD
bremelanotide
AstraZeneca halts development of anti-obesity drug
Marketwatch
Mon, 09/10/12 - 11:23 am
obesity
Palatin
AstraZeneca
AZD2820
Merck's $303 Million Ambryx Deal Great For Investors
Seeking Alpha
Thu, 06/28/12 - 06:03 pm
Merck
Ambryx
AstraZeneca
GSK
Novartis
Pfizer
Palatin
5 Dirt Cheap Biotech Stocks Poised to Triple
Seeking Alpha
Tue, 06/28/11 - 08:53 am
Adventrx
Chelsea Therapeutics
Keryx
Palatin
Rexahn
Palatin cuts half its workforce, discovery R&D
Fierce Biotech
Tue, 09/28/10 - 12:34 pm
Palatin
layoffs